These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29524546)
1. An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii. Abdollahi S; Rasooli I; Mousavi Gargari SL Microb Pathog; 2018 May; 118():18-31. PubMed ID: 29524546 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical and structural characterization, epitope mapping and vaccine potential investigation of a new protein containing Tetratrico Peptide Repeats of Acinetobacter baumannii: An in-silico and in-vivo approach. Abdollahi S; Raoufi Z; Fakoor MH Mol Immunol; 2021 Dec; 140():22-34. PubMed ID: 34649027 [TBL] [Abstract][Full Text] [Related]
3. Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: An innovative approach. Jahangiri A; Rasooli I; Owlia P; Imani Fooladi AA; Salimian J J Microbiol Methods; 2018 Jan; 144():79-85. PubMed ID: 29133159 [TBL] [Abstract][Full Text] [Related]
4. The role of TonB-dependent copper receptor in virulence of Acinetobacter baumannii. Abdollahi S; Rasooli I; Mousavi Gargari SL Infect Genet Evol; 2018 Jun; 60():181-190. PubMed ID: 29505819 [TBL] [Abstract][Full Text] [Related]
5. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery. Ahmad S; Ranaghan KE; Azam SS Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936 [TBL] [Abstract][Full Text] [Related]
6. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A. Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426 [TBL] [Abstract][Full Text] [Related]
7. Functional features of TonB energy transduction systems of Acinetobacter baumannii. Zimbler DL; Arivett BA; Beckett AC; Menke SM; Actis LA Infect Immun; 2013 Sep; 81(9):3382-94. PubMed ID: 23817614 [TBL] [Abstract][Full Text] [Related]
8. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii. Ahmad S; Azam SS J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164 [TBL] [Abstract][Full Text] [Related]
9. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice. Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309 [TBL] [Abstract][Full Text] [Related]
10. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. Hassan A; Naz A; Obaid A; Paracha RZ; Naz K; Awan FM; Muhmmad SA; Janjua HA; Ahmad J; Ali A BMC Genomics; 2016 Sep; 17(1):732. PubMed ID: 27634541 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology. Ni Z; Chen Y; Ong E; He Y Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771 [TBL] [Abstract][Full Text] [Related]
12. In silico determination and validation of baumannii acinetobactin utilization a structure and ligand binding site. Sefid F; Rasooli I; Jahangiri A Biomed Res Int; 2013; 2013():172784. PubMed ID: 24106696 [TBL] [Abstract][Full Text] [Related]
13. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection. Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813 [TBL] [Abstract][Full Text] [Related]
14. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286 [No Abstract] [Full Text] [Related]
15. In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate. Hosseingholi EZ; Rasooli I; Gargari SL Acta Biotheor; 2014 Dec; 62(4):455-78. PubMed ID: 24957752 [TBL] [Abstract][Full Text] [Related]
16. In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii. Hessami A; Mogharari Z; Rahim F; Khalesi B; Jamal Nassrullah O; Reza Rahbar M; Khalili S; Jahangiri A Int Immunopharmacol; 2024 Dec; 142(Pt A):113066. PubMed ID: 39241518 [TBL] [Abstract][Full Text] [Related]
17. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb. Garg N; Singh R; Shukla G; Capalash N; Sharma P Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015 [TBL] [Abstract][Full Text] [Related]
18. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach. Piri-Gharaghie T; Doosti A; Mirzaei SA Appl Biochem Biotechnol; 2022 Oct; 194(10):4892-4914. PubMed ID: 35670904 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection. Aghajani Z; Rasooli I; Mousavi Gargari SL APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768 [TBL] [Abstract][Full Text] [Related]
20. Antigen Epitope Developed Based on Song X; Zhao G; Ding M Biomed Res Int; 2020; 2020():1975875. PubMed ID: 33134372 [No Abstract] [Full Text] [Related] [Next] [New Search]